Additionally, investigating the impact of MMACHC mutations and their correlation with clinical outcomes will provide valuable insights into the pathophysiology of CblC disease and guide the development of targeted therapies. Here, MMACHC is linked to methylmalonic aciduria and homocystinuria type cblC.